SCHEMBL16414432

SCHEMBL16414432

CC(=O)c1c(F)cncc1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B2 P19099 3/20 0.39
▸ KMT2A Q03164 2/20 0.36
▸ THRB P10828 1/20 0.36
▸ CYP11B1 P15538 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ HCAR2 Q8TDS4 2/20 0.35
▸ CSNK1A1 P48729 1/20 0.33
▸ CSNK1D P48730 1/20 0.33
▸ CLK2 P49760 1/20 0.33
▸ CSNK1G1 Q9HCP0 1/20 0.33
▸ USP7 Q93009 1/20 0.33
▸ CES2 O00748 1/20 0.32
▸ CES1 P23141 1/20 0.32
▸ MKNK1 Q9BUB5 1/20 0.32
▸ MKNK2 Q9HBH9 1/20 0.32
▸ RIPK1 Q13546 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30765126 0.85 USP7 (0.38) CYP11B2CYP11B1CYP3A4USP7
SCHEMBL1770151 0.85 CYP11B2 (0.35) CYP11B2KMT2ATHRBCYP11B1MEN1
SCHEMBL30765119 0.85 USP7 (0.38) CYP11B2CYP11B1CYP3A4USP7
SCHEMBL23111961 0.85 USP7 (0.38) CYP11B2CYP11B1CYP3A4USP7
SCHEMBL24935433 0.78 CYP11B2 (0.34) CYP11B2KMT2A
SCHEMBL29632577 0.78 CYP11B2 (0.34) CYP11B2KMT2A
SCHEMBL24806315 0.75 ADORA3 (0.37) CYP11B2HCAR2CSNK1A1CSNK1DCLK2
SCHEMBL723235 0.75 ALDH1A1 (0.38) HCAR2CES2CES1ALDH1A1
SCHEMBL3348369 0.75 ATM (0.46) CYP11B2CYP3A4HPGDTSHRMAPK1
SCHEMBL14864587 0.73 KDM4E (0.33) CYP11B2KMT2ATHRBMEN1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2865446-B1 PROCESS FOR PRODUCING OPTICALLY ACTIVE SECONDARY ALCOHOL KANTO KAGAKU (JP) 2021-09-22 — — EP disclosed
US-9174906-B2 Process for producing optically active secondary alcohol KANTO KAGAKU KABUSHIKI KAISHA (JP) 2015-11-03 — — US disclosed
EP-2865446-A1 Process for producing optically active secondary alcohol Kanto Kagaku Kabushiki Kaisha (JP) 2015-04-29 — — EP disclosed
US-20150031920-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE SECONDARY ALCOHOL NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2015-01-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150031920-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE SECONDARY ALCOHOL ADH1A, ADH1C, ADH5 CYP11B2 184/4885KMT2A 1514/4885THRB 1028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback